earnings
confidence high
sentiment negative
materiality 0.60
Pro-Dex Q3 revenue up 9% to $14.3M; net income falls to $0.19 EPS on investment losses
PRO DEX INC
2024-Q3 EPS reported
$0.15
revenue$38,819,000
- Net sales $14.3M (+9% YoY); operating income $2.2M (+7%) driven by medical device revenue.
- Net income $655k ($0.19 diluted EPS) vs $1.6M ($0.45) prior year; decline due to $1.2M unrealized loss on investments.
- Nine-month net sales $38.8M (+10%); operating income $4.8M (+16%).
- Nine-month net income $540k ($0.15 diluted EPS) vs $5.6M ($1.52) due to $3.8M unrealized investment losses.
- CEO Rick Van Kirk says company tracking toward record revenue year; confident in momentum into FY2025.